tiprankstipranks

Arnold Hanish Insider Profile

4 Followers
Arnold Hanish, Director at Decoy Therapeutics, holds 3.42K shares in Decoy Therapeutics (Ticker: DCOY), holds 12.40K shares in Omeros (Ticker: OMER), holds 26.20K shares in Eli Lilly & Co (Ticker: LLY).
tipranks
Arnold Hanish

Arnold Hanish
Decoy Therapeutics (DCOY)
Director

Ranked #23,558 out of 108,921 Corporate Insiders

Profitable Transactions

33%
3 out of 9 Profitable Transactions

Average Return

+8.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$30M
99.20%
0.77%
0.03%
A breakdown of Arnold Hanish's holdings

Insider Roles

Eli Lilly & Co
(LLY)
CAO
Omeros
(OMER)
Director
Decoy Therapeutics
(DCOY)
Director
Roles that Arnold Hanish holds in companies

Most Profitable Insider Trade

Stock:
Decoy Therapeutics
(DCOY)
Rating:Informative Buy
Date:Feb 12, 2020 - Feb 12, 2021
Return:+211.20%
The most profitable trade made by Arnold Hanish

Arnold Hanish's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Decoy Therapeutics
Sep 02, 2026
Director
Uninformative Buy
$9.19K
Omeros
Aug 28, 2026
Director
Uninformative Buy
228.53K
$234.98K
Eli Lilly & Co
Oct 29, 2012
CAO
Uninformative Sell
$30.11M
List of latest transactions for each holding click on a transaction to see Arnold Hanish's performance on stock

Arnold Hanish insider profile FAQ

What is the percentage of profitable transactions made by Arnold Hanish?
The percentage of profitable transactions made by Arnold Hanish is 33%.
    What is the average return per transaction made by Arnold Hanish?
    The average return per transaction made by Arnold Hanish is 8.10%.
      What stocks does Arnold Hanish hold?
      Arnold Hanish holds: DCOY, OMER, LLY stocks.
        What was Arnold Hanish’s latest transaction?
        Arnold Hanish latest transaction was an Uninformative Buy of ―.
          What was Arnold Hanish's most profitable transaction?
          Arnold Hanish’s most profitable transaction was an Informative Buy of DCOY stock on February 12, 2020. The return on the trade was 211.20%.
            What is Arnold Hanish's role in Decoy Therapeutics?
            Arnold Hanish's role in Decoy Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.